Mahamaya Lifesciences Ipo
Mahamaya Lifesciences IPO Review & Key Points
Review:
IPO Lead Managers aka Merchant Bankers
Oneview Corporate Advisors Pvt.Ltd.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | – | – | ₹- |
| Retail Maximum | – | – | ₹- |
| S-HNI Minimum | – | – | ₹- |
| S-HNI Maximum | – | – | ₹- |
| B-HNI Minimum | – | – | ₹- |
| Investor Category | Share Offered | -% Shares |
| Anchor Investor | – Shares | -% |
| QIB (Ex. Anchor) | – Shares | 50% |
| NII Shares Offered | – Shares | 15% |
| Retail Shares Offered | – Shares | 35% |
| Anchor Bidding Date | 2025 |
| Anchor Investors List | |
| Shares Offered | [.] Shares |
| Anchor Size | [.] Cr. |
| lock-in period end date 50% shares (30 Days) | 2025 |
| lock-in period end date 50% shares (90 Days) | 2025 |
| IPO Open Date: | 2025 |
| IPO Close Date: | 2025 |
| Basis of Allotment: | 2025 |
| Refunds: | 2025 |
| Credit to Demat Account: | 2025 |
| IPO Listing Date: | 2025 |
| IPO Bidding Cut-off Time: | 2025 – 5 PM |
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 1,77,66,200 | 77.27% |
| Promoter Holding Post Issue | – | -% |
| Purpose | Crores |
| Purchase of Equipment for existing Formulation plant. | ₹- |
| Funding capital expenditure towards setting up of a new Technical manufacturing plant. | ₹- |
| Construction of Warehouse Building and Purchase of Machinery. | ₹- |
| Funding working capital requirement of the Company. | ₹- |
| General Corporate purposes. | ₹- |
| Period Ended | Revenue | Expense | PAT | Assets |
| 2022 | ₹90.16 | ₹86.43 | ₹2.72 | ₹55.71 |
| 2023 | ₹137.4 | ₹132.30 | ₹3.75 | ₹77.88 |
| 2024 | ₹162.83 | ₹155.71 | ₹5.22 | ₹112.07 |
| September 2024 | ₹147.15 | ₹137.17 | ₹7.41 | ₹151.95 |
| KPI | Values |
| ROE: | 23.67% |
| ROCE: | 32.38% |
| EBITDA Margin: | 8.20% |
| PAT Margin: | 3.20% |
| Debt to equity ratio: | 1.05 |
| Earning Per Share (EPS): | ₹3.80 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 21.16% |
| Net Asset Value (NAV): | ₹17.95 |
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Nova Agritech Limited | 4.2 | 15.14 | 14.64% | 21.45 | 252.51 Cr. |
| Bhagiradha Chemicals & Industries Limited | 1.75 | 169.65 | 4.46% | 397.59 | 410.33 Cr. |
| IPO Open Date | 2025 |
| IPO Close Date | 2025 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹[.] to ₹[.] Per Share |
| Issue Size | Approx ₹[.] Crores |
| Fresh Issue | Approx ₹[.] Crores |
| Offer for Sale: | Approx 5,40,000 Equity Shares |
| Issue Type | Book Built Issue |
| IPO Listing | BSE SME |
| DRHP Draft Prospectus | |
| RHP Draft Prospectus |